Michaela Dinboeck | Head Patient Engagement
Novartis

Michaela leads Patient Engagement at Novartis. In this role she is responsible for the PE strategy and systematic implementation across the company portfolio, starting at early development stage, through to regulatory and value dossier submissions. This work is based on long term strategic partnerships with the patient community. PE Science and Clinical Representativeness (CR) experts develop robust methods for Patient Experience Data (PED) generation and ensure the intended population for developed innovations, is represented in clinical programs. Dedicated functional experts in PE Governance, Capability building and Measurement, ensure continuous progress in Patient Focused Drug Development (PFDD). The vision is to deeply embed Patient Focused Drug Development along the lifecycle of medicines, to ensure decision making is grounded in patient experiences and needs. Michaela joined Patient Engagement in 2017 after 20 years in Commercial and General Management positions within the Pharmaceutical and Medical Device Industry at country, regional and global level. In her roles she has worked across multiple disease areas in established and emerging health care systems. She has lectured Business at Universities in Bolivia and Malaysia and currently lives with her husband and two children in Basel, Switzerland.